$ONCO
Onconetix, Inc. Stock $onco

$onco Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024045172 Filed on May 20, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q1
Revenue	$700.4K	$58.47K	$0.00
YoY Change
Cost Of Revenue	$511.4K	$1.186M
YoY Change
Gross Profit	$189.0K	-$1.127M
YoY Change
Gross Profit Margin	26.98%	-1927.76%
Selling, General & Admin	$3.736M	$6.433M	$1.766M
YoY Change	111.57%	215.3%	9.31%
% of Gross Profit	1976.96%
Research & Development	$48.96K	-$198.9K	$1.082M
YoY Change	-95.48%	-116.5%	137.81%
% of Gross Profit	25.91%
Depreciation & Amortization	$206.7K	$43.94K	$1.698K
YoY Change	12073.14%	2288.04%	30.62%
% of Gross Profit	109.37%
Operating Expenses	$11.27M	$6.234M	$2.848M
YoY Change	295.72%	92.06%	37.55%
Operating Profit	-$11.08M	-$7.361M	-$2.848M
YoY Change	289.08%		37.55%
Interest Expense	-$186.7K	-$314.8K	$1.620K
YoY Change	-11622.22%	-1222.72%
% of Operating Profit
Other Income/Expense, Net	$6.000K		$1.615K
YoY Change	271.52%
Pretax Income	-$11.24M	-$22.36M	-$2.847M
YoY Change	294.86%	594.96%	37.48%
Income Tax	-$121.6K	-$12.59K
% Of Pretax Income
Net Earnings	-$11.12M	-$22.35M	-$2.847M
YoY Change	290.59%	594.57%	37.48%
Net Earnings / Revenue	-1587.39%	-38226.22%
Basic Earnings Per Share	-$0.50		-$0.18
Diluted Earnings Per Share	-$0.50	-$1.17	-$0.18
COMMON SHARES
Basic Shares Outstanding	22.15M shares	17.99M shares	15.91M shares
Diluted Shares Outstanding	22.15M shares		15.91M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.464M	$4.554M	$20.26M
YoY Change	-77.96%	-82.32%	8.85%
Cash & Equivalents	$4.464M	$4.554M	$21.26M
Short-Term Investments
Other Short-Term Assets	$1.182M	$770.2K	$2.146M
YoY Change	-44.94%	64.13%	552.74%
Inventory	$396.3K	$364.1K
Prepaid Expenses			$780.2K
Receivables	$252.8K	$149.7K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$6.295M	$5.838M	$22.47M
YoY Change	-71.99%	-77.77%	17.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$56.76K	$60.65K	$14.21K
YoY Change	299.46%	330.51%	-7.73%
Goodwill	$46.74M	$55.68M
YoY Change
Intangibles	$21.45M	$25.41M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$373.9K	$383.5K	$15.50K
YoY Change	2312.32%	893.11%	-92.86%
Total Long-Term Assets	$68.74M	$81.68M	$29.71K
YoY Change	231259.48%	154872.41%	-87.22%
TOTAL ASSETS
Total Short-Term Assets	$6.295M	$5.838M	$22.47M
Total Long-Term Assets	$68.74M	$81.68M	$29.71K
Total Assets	$75.03M	$87.52M	$22.50M
YoY Change	233.44%	232.64%	16.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.251M	$5.295M	$1.503M
YoY Change	182.81%	253.17%	65.64%
Accrued Expenses	$1.936M	$2.200M	$1.293M
YoY Change	49.74%	-8.69%	-31.71%
Deferred Revenue
YoY Change
Short-Term Debt	$15.18M	$9.618M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$21.43M	$17.19M	$2.809M
YoY Change	663.14%	338.25%	0.27%
LONG-TERM LIABILITIES
Long-Term Debt	$110.9K	$118.9K	$0.00
YoY Change
Other Long-Term Liabilities	$1.006M	$1.495M
YoY Change
Total Long-Term Liabilities	$1.116M	$1.613M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.43M	$17.19M	$2.809M
Total Long-Term Liabilities	$1.116M	$1.613M	$0.00
Total Liabilities	$25.29M	$21.88M	$2.809M
YoY Change	800.56%	457.75%	0.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$67.90M	-$56.79M	-$22.22M
YoY Change	205.56%	193.07%
Common Stock	$228.00	$228.00	$164.00
YoY Change	39.02%	45.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$625.8K	$625.8K	$600.3K
YoY Change	4.25%	10.41%
Treasury Stock Shares
Shareholders Equity	-$21.53M	-$5.602M	$19.69M
YoY Change
Total Liabilities & Shareholders Equity	$75.03M	$87.52M	$22.50M
YoY Change	233.44%	232.64%	16.38%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q1
OPERATING ACTIVITIES
Net Income	-$11.12M	-$22.35M	-$2.847M
YoY Change	290.59%	594.57%	37.48%
Depreciation, Depletion And Amortization	$206.7K	$43.94K	$1.698K
YoY Change	12073.14%	2288.04%	30.62%
Cash From Operating Activities	-$5.200M	-$4.311M	-$4.446M
YoY Change	16.96%	53.9%	401.76%
INVESTING ACTIVITIES
Capital Expenditures	$4.578K	$4.820K	$1.819K
YoY Change	151.68%		-134.98%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.216M
YoY Change
Cash From Investing Activities	-$4.578K	$1.211M	-$1.819K
YoY Change	151.68%		-65.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$5.205M	-4.940K	-$48.95K
YoY Change	-10732.62%	-99.15%	-100.28%
NET CHANGE
Cash From Operating Activities	-$5.200M	-4.311M	-$4.446M
Cash From Investing Activities	-$4.578K	1.211M	-$1.819K
Cash From Financing Activities	$5.205M	-4.940K	-$48.95K
Net Change In Cash	-$90.47K	-3.105M	-$4.497M
YoY Change	-97.99%	-8.25%	-126.96%
FREE CASH FLOW
Cash From Operating Activities	-$5.200M	-$4.311M	-$4.446M
Capital Expenditures	$4.578K	$4.820K	$1.819K
Free Cash Flow	-$5.205M	-$4.316M	-$4.448M
YoY Change	17.01%	54.07%	404.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15910415	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22147598	shares
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41294
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	Onconetix, Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-2262816
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	201 E. Fifth Street
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1900
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Cincinnati
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	45202
CY2024Q1	dei	City Area Code CityAreaCode	(513)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	620-4101
CY2024Q1	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value
CY2024Q1	dei	Trading Symbol TradingSymbol	ONCO
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22327701	shares
CY2024Q1	us-gaap	Cash Cash	4463870	usd
CY2023Q4	us-gaap	Cash Cash	4554335	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	252792	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	149731	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	396312	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	364052	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1181723	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	770153	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	6294697	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5838271	usd
CY2024Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	7792	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	17423	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	56763	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60654	usd
CY2024Q1	us-gaap	Deferred Costs DeferredCosts	366113	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	366113	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	109360	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	148542	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21453555	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25410887	usd
CY2024Q1	us-gaap	Goodwill Goodwill	46743319	usd
CY2023Q4	us-gaap	Goodwill Goodwill	55676142	usd
CY2024Q1	us-gaap	Assets Assets	75031599	usd
CY2023Q4	us-gaap	Assets Assets	87518032	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4251394	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5295114	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1936014	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2199867	usd
CY2024Q1	bwv	Notes Payable Net Of Debt Discount NotesPayableNetOfDebtDiscount	198699	usd
CY2023Q4	bwv	Notes Payable Net Of Debt Discount NotesPayableNetOfDebtDiscount	381627	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	10406394	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	9618373	usd
CY2024Q1	bwv	Notes Payable Net Of Related Party NotesPayableNetOfRelatedParty	225226	usd
CY2023Q4	bwv	Notes Payable Net Of Related Party NotesPayableNetOfRelatedParty	0	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	62480	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	74252	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2641	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2641	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	21433697	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17190247	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	110871	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	118857	usd
CY2024Q1	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	321132	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	556296	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46880	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	74290	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2743246	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3073781	usd
CY2024Q1	us-gaap	Liabilities Liabilities	25293426	usd
CY2023Q4	us-gaap	Liabilities Liabilities	21877471	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	64236085	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	64236085	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22845100	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22841975	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22327701	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22324576	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	228	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	228	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49452674	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49428809	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	517399	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	517399	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	625791	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	625791	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67904766	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-56786194	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2455546	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2380920	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-21533201	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-5602028	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	7035289	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	7006504	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14497912	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1404476	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	75031599	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	87518032	usd
CY2024Q1	us-gaap	Revenues Revenues	700433	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	511433	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	189000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3736450	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1766022	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	48964	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1082237	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5192000	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	2293576	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	11270990	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2848259	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11081990	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2848259	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	225063	usd
CY2024Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	187993	usd
CY2024Q1	bwv	Change In Fair Value Of Subscription Agreement Liability ChangeInFairValueOfSubscriptionAgreementLiability	226400	usd
CY2024Q1	us-gaap	Other Income OtherIncome	28507	usd
CY2023Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	1615	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-158149	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1615	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11240139	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2846644	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-121567	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-11118572	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2846644	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.5
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22147598	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15910415	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-11118572	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2846644	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	4991144	usd
CY2024Q1	bwv	Change In Pension Benefit Obligation ChangeInPensionBenefitObligation	154678	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15955038	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2846644	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1404476	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	52650	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	4991144	usd
CY2024Q1	bwv	Stock Issued During Period Value Of Changes In Pension Benefit Obligation StockIssuedDuringPeriodValueOfChangesInPensionBenefitObligation	154678	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-11118572	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14497912	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22388002	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	185578	usd
CY2023Q1	bwv	Purchase Of Treasury Shares PurchaseOfTreasuryShares	33454	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2846644	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19693482	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-11118572	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2846644	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5192000	usd
CY2024Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	2293576	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	182928	usd
CY2024Q1	bwv	Amortization Of Debt Discount Related Party AmortizationOfDebtDiscountRelatedParty	174774	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	206700	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1698	usd
CY2024Q1	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	-226400	usd
CY2024Q1	us-gaap	Pension Expense PensionExpense	-58404	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	52650	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	185578	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	50000	usd
CY2023Q1	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	1615	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-121567	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	116763	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	36974	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	419530	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	321961	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	7750	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-23117	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1017428	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1237493	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-261303	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-214311	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	135198	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	139208	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	256148	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5232063	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4411631	usd
CY2023Q1	bwv	Receivable From Related Parties1 ReceivableFromRelatedParties1	34452	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4578	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1819	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4578	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36271	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	5000000	usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	678550	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	400000	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	73457	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	15500	usd
CY2023Q1	bwv	Payments For Purchase Of Treasury Shares PaymentsForPurchaseOfTreasuryShares	33454	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5205093	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-48954	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-58917	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-90465	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4496856	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4554335	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25752659	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4463870	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21255803	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	4405	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	339593	usd
CY2023Q1	bwv	Deferred Offering Costs Previously Prepaid DeferredOfferingCostsPreviouslyPrepaid	-11020	usd
CY2023Q1	bwv	Exerciseofprefundedwarrants Exerciseofprefundedwarrants	7	usd
CY2024Q1	us-gaap	Investments And Cash InvestmentsAndCash	4500000	usd
CY2024Q1	us-gaap	Capital Units CapitalUnits	15100000	usd
CY2024Q1	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	-67900000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5200000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. The most significant estimates in the Company’s consolidated financial statements relate to accounting for acquisitions, valuation of inventory, the useful life of the amortizable intangible assets, estimates of future cash flows used to evaluate impairment of intangible assets, assumptions related to the pension benefit obligation, assumptions related to the related party subscription agreement liability, the valuation of preferred stock, and accounting for income taxes. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company’s future results of operations will be affected.</p>
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023Q4	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2641	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	640241	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2641	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	866641	usd
CY2024Q1	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	700000	usd
CY2024Q1	us-gaap	Accounts Receivable Sale AccountsReceivableSale	253000	usd
CY2023	us-gaap	Accounts Receivable Sale AccountsReceivableSale	150000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	194805	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4966	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	30039	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	396312	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	364052	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	796282	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	122004	usd
CY2024Q1	us-gaap	Prepaid Rent PrepaidRent	208367	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	312551	usd
CY2024Q1	bwv	Prepaids Research And Development PrepaidsResearchAndDevelopment	89195	usd
CY2023Q4	bwv	Prepaids Research And Development PrepaidsResearchAndDevelopment	89195	usd
CY2023Q4	bwv	Prepaid Professional Fees PrepaidProfessionalFees	70708	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	87879	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	175695	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1181723	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	770153	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25447699	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2276194	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	1488307	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	21683198	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-36812	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	-201593	usd
CY2024Q1	bwv	Accumulated Amortization Foreign Currency Translation AccumulatedAmortizationForeignCurrencyTranslation	8762	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-229643	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25410887	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21453555	usd
CY2024Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P15Y
CY2024Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	171000	usd
CY2024Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	31000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	598786	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	968457	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	968457	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	968457	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	968457	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	8293916	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12766530	usd
CY2024Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P14Y25D
CY2024Q1	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	8700000	usd
CY2023Q4	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	9300000	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	5200000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	55676142	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5192000	usd
CY2024Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	3740823	usd
CY2024Q1	us-gaap	Goodwill Goodwill	46743319	usd
CY2024Q1	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	568559	usd
CY2023Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	487579	usd
CY2024Q1	bwv	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	463506	usd
CY2023Q4	bwv	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	616707	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	445569	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	550415	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	264593	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	265849	usd
CY2024Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	93787	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	93787	usd
CY2024Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	50000	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	60530	usd
CY2024Q1	bwv	Accrued Interest Related Party AccruedInterestRelatedParty	50000	usd
CY2023Q4	bwv	Accrued Deferred Offering Costs AccruedDeferredOfferingCosts	125000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1936014	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2199867	usd
CY2024Q1	bwv	Royalty Sales Percentage RoyaltySalesPercentage	0.06	pure
CY2024Q1	bwv	Sales Payments Amount SalesPaymentsAmount	22500000	usd
CY2023Q4	bwv	Aggregate Purchase Shares AggregatePurchaseShares	5709935	shares
CY2024Q1	bwv	Business Transaction Yeare BusinessTransactionYeare	P5Y
CY2024Q1	us-gaap	Asset Acquisition Consideration Transferred Other Assets AssetAcquisitionConsiderationTransferredOtherAssets	6000000	usd
CY2024Q1	us-gaap	Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable	12947000	usd
CY2024Q1	us-gaap	Asset Acquisition Consideration Transferred Transaction Cost AssetAcquisitionConsiderationTransferredTransactionCost	79771	usd
CY2024Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	19026771	usd
CY2024Q1	bwv	Inventory Fair Value InventoryFairValue	300000	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2300000	usd
CY2023Q4	bwv	Impairment Charge ImpairmentCharge	14700000	usd
CY2023Q4	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	1200000	usd
CY2023Q4	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	1	pure
CY2024Q1	us-gaap	Business Acquisition Pro Forma Information Description BusinessAcquisitionProFormaInformationDescription	(i) $3.5 million in cash at signing of the WraSer APA; (ii) $4.5 million in cash on the later of (x) 90 days after the signing of the WraSer APA or (y) the date that all closing conditions under the WraSer APA are met or otherwise waived (the “WraSer Closing Date”); (iii) 1.0 million shares of the Company’s common stock (the “Closing Shares”) issuable on the WraSer Closing Date, and (iv) $500,000 in cash one year from the WraSer Closing Date.
CY2024Q1	bwv	Initial Payment Amount InitialPaymentAmount	3500000	usd
CY2024Q1	bwv	Payments Payments	3500000	usd
CY2024Q1	us-gaap	Deposits Deposits	3500000	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	1100000	usd
CY2023Q3	us-gaap	Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Costs BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts	500000	usd
CY2023Q4	bwv	Voting Interest Percentage VotingInterestPercentage	1	pure
CY2023Q4	bwv	Stock Issued During Period Shares Issuance Of Common Stock And Series B Preferred Stock In Connection With Pmx Transaction StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndSeriesBPreferredStockInConnectionWithPMXTransaction	3675414	shares
CY2024Q1	bwv	Royalty Rate RoyaltyRate	0.06	pure
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1500000	usd
CY2023Q3	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2025-07-14
CY2024Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	1500000	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	1800000	usd
CY2024Q1	bwv	Milestone Payments MilestonePayments	2500000	usd
CY2024Q1	bwv	Milestone Payments Paid MilestonePaymentsPaid	500000	usd
CY2024Q1	bwv	Payable Average Discount Rate Percentage PayableAverageDiscountRatePercentage	0.082	pure
CY2024Q1	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	400000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	200000	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	4000000	usd
CY2023Q3	bwv	Debt Instrument Due Date DebtInstrumentDueDate	2023-09-30
CY2023Q3	bwv	Cash Payment To The Seller CashPaymentToTheSeller	1000000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	490000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	5000000	usd
CY2024Q1	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.04	pure
CY2024Q1	us-gaap	Interest And Dividends Payable Current And Noncurrent InterestAndDividendsPayableCurrentAndNoncurrent	5000000	usd
CY2024Q1	us-gaap	Interest Expense Other InterestExpenseOther	200000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	200000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	50000	usd
CY2024Q1	bwv	Financing Fees FinancingFees	700000	usd
CY2024Q1	us-gaap	Investment Interest Rate Paid In Kind InvestmentInterestRatePaidInKind	0.0779	pure
CY2024Q1	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	600000	usd
CY2024Q1	bwv	Installment Payments installmentPayments	78000	usd
CY2023Q4	bwv	Sale Of Units SaleOfUnits	20000000	shares
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.25
CY2024Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.25
CY2024Q1	us-gaap	Servicing Liability At Fair Value Additions ServicingLiabilityAtFairValueAdditions	638000	usd
CY2023	us-gaap	Servicing Liability At Fair Value Additions ServicingLiabilityAtFairValueAdditions	864000	usd
CY2024Q1	us-gaap	Servicing Liability At Fair Value Amount ServicingLiabilityAtFairValueAmount	226000	usd
CY2024Q1	us-gaap	Product Liability Contingency Third Party Recovery Percentage ProductLiabilityContingencyThirdPartyRecoveryPercentage	0.35	pure
CY2023	us-gaap	Product Liability Contingency Third Party Recovery Percentage ProductLiabilityContingencyThirdPartyRecoveryPercentage	0.55	pure
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	3000000	usd
CY2024Q1	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	5709935	shares
CY2023Q4	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	2696729	shares
CY2024Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	269672900	shares
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	32638	shares
CY2023Q1	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	1.03
CY2023Q1	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	33500	usd
CY2024Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	4500000	usd
CY2023Q1	bwv	Fixed Commission Rate FixedCommissionRate	0.03	pure
CY2024Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	300000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7899661	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.68
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	7899661	shares
CY2024Q1	us-gaap	Forward Contract Indexed To Equity Settlement Share Fair Value Per Share ForwardContractIndexedToEquitySettlementShareFairValuePerShare	0.15
CY2024Q1	bwv	Warrants Issuable WarrantsIssuable	3000	usd
CY2024Q1	us-gaap	Option Indexed To Issuers Equity Settlement Alternatives Shares At Fair Value OptionIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue	447519	shares
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3150000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.08
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	83000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	272000	usd
CY2023Q2	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	150000	shares
CY2023Q2	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	25440	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	256580	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.03
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3125	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.17
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	118750	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.03
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	140955	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.98
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.46
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.16
CY2024Q1	us-gaap	Shares Held In Employee Stock Option Plan Allocated SharesHeldInEmployeeStockOptionPlanAllocated	57546	shares
CY2024Q1	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	3.16
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y7D
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52650	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	185578	usd
CY2022Q2	us-gaap	Short Term Lease Payments ShortTermLeasePayments	14000	usd
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	48000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	4000	usd
CY2024Q1	bwv	Percentage Of Subscription PercentageOfSubscription	0.02	pure
CY2024Q1	bwv	Aggregate Payments AggregatePayments	59750000	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	209000	usd
CY2023	us-gaap	Dividends Paidinkind DividendsPaidinkind	159000	usd
CY2023	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	50000	usd
CY2024Q1	us-gaap	Other Receivables OtherReceivables	363000	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	usd
CY2023Q4	bwv	Subscription Agreement Pmx Investor Percentage SubscriptionAgreementPMXInvestorPercentage	0.05	pure
CY2024Q1	us-gaap	Other Expenses OtherExpenses	6000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	100000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.213	pure
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1366865	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1469102	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	7899661	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	5264274	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	140955	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	5709935	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	15117416	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6733376	shares
CY2024Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0145	pure
CY2023Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0145	pure
CY2024Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate	0.0145	pure
CY2023Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate	0.0145	pure
CY2024Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.03	pure
CY2023Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.03	pure
CY2024Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	24650	usd
CY2024Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	7558	usd
CY2024Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	23495	usd
CY2024Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	15446	usd
CY2024Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-6733	usd
CY2024Q1	us-gaap	Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitContributions	21400	usd
CY2024Q1	bwv	Cash Receipts Percentage CashReceiptsPercentage	0.15	pure
CY2024Q1	bwv	Net Proceeds Percentage NetProceedsPercentage	0.10	pure
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q1	us-gaap	Revenues Revenues		usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q1	us-gaap	Gross Profit GrossProfit		usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill		usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense		usd
CY2023Q1	bwv	Change In Fair Value Of Subscription Agreement Liability ChangeInFairValueOfSubscriptionAgreementLiability		usd
CY2023Q1	us-gaap	Other Income OtherIncome		usd
CY2024Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax		usd
CY2023Q1	bwv	Change In Pension Benefit Obligation ChangeInPensionBenefitObligation		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q1	bwv	Exercise Of Prefunded Warrants ExerciseOfPrefundedWarrants		usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss		usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2023Q1	bwv	Amortization Of Debt Discount Related Party AmortizationOfDebtDiscountRelatedParty		usd
CY2023Q1	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices		usd
CY2023Q1	us-gaap	Pension Expense PensionExpense		usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2024Q1	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment		usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2024Q1	bwv	Receivable From Related Parties1 ReceivableFromRelatedParties1		usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2024Q1	bwv	Payments For Purchase Of Treasury Shares PaymentsForPurchaseOfTreasuryShares		usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2024Q1	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1		usd
CY2024Q1	bwv	Deferred Offering Costs Previously Prepaid DeferredOfferingCostsPreviouslyPrepaid		usd
CY2024Q1	bwv	Exerciseofprefundedwarrants Exerciseofprefundedwarrants		usd
CY2024Q1	bwv	Prepaid Professional Fees PrepaidProfessionalFees		usd
CY2023Q4	bwv	Accrued Interest Related Party AccruedInterestRelatedParty		usd
CY2024Q1	bwv	Accrued Deferred Offering Costs AccruedDeferredOfferingCosts		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends		shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001782107

Files In Submission

Name	View Source	Status
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
0001213900-24-045172-index-headers.html	Edgar Link	pending
0001213900-24-045172-index.html	Edgar Link	pending
0001213900-24-045172.txt	Edgar Link	pending
0001213900-24-045172-xbrl.zip	Edgar Link	pending
bwv-20240331.xsd	Edgar Link	pending
ea0206102-10q_onconetix.htm	Edgar Link	pending
ea020610201ex31-1_onconetix.htm	Edgar Link	pending
ea020610201ex31-2_onconetix.htm	Edgar Link	pending
ea020610201ex32-1_onconetix.htm	Edgar Link	pending
ea020610201ex32-2_onconetix.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
bwv-20240331_cal.xml	Edgar Link	unprocessable
bwv-20240331_def.xml	Edgar Link	unprocessable
bwv-20240331_lab.xml	Edgar Link	unprocessable
bwv-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0206102-10q_onconetix_htm.xml	Edgar Link	completed
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONCO
Onconetix, Inc. Stock $onco

2024 Q1 Form 10-Q Financial Statement

#000121390024045172 Filed on May 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONCO Onconetix, Inc. Stock $onco

2024 Q1 Form 10-Q Financial Statement

#000121390024045172 Filed on May 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONCO
Onconetix, Inc. Stock $onco